Skip to main content
Nuwellis, Inc. (NUWE)
NASDAQ: NUWE · IEX Real-Time Price · USD
0.262
-0.014 (-5.11%)
At close: May 31, 2024, 4:00 PM
0.260
-0.002 (-0.76%)
After-hours: May 31, 2024, 7:15 PM EDT

Nuwellis Revenue

Nuwellis had revenue of $8.90M in the twelve months ending March 31, 2024, with 5.35% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $1.86M with 1.70% year-over-year growth. In the year 2023, Nuwellis had annual revenue of $8.86M with 3.76% growth.

Revenue (ttm)
$8.90M
Revenue Growth
+5.35%
P/S Ratio
0.53
Revenue / Employee
$150,763
Employees
59
Market Cap
4.73M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20238.86M321.00K3.76%
Dec 31, 20228.54M622.00K7.85%
Dec 31, 20217.92M480.00K6.45%
Dec 31, 20207.44M1.93M35.02%
Dec 31, 20195.51M513.00K10.26%
Dec 31, 20185.00M1.45M40.67%
Dec 31, 20173.55M2.26M175.64%
Dec 31, 20161.29M1.23M2,084.75%
Dec 31, 201559.00K-236.00K-80.00%
Dec 31, 2014295.00K236.00K400.00%
Dec 31, 201359.00K--
Dec 31, 20120--
Dec 31, 20110--
Dec 31, 2010407.00K183.00K81.70%
Dec 31, 2009224.00K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Regional Health Properties 17.39M
China Pharma Holdings 6.42M
Sintx Technologies 2.78M
Lipella Pharmaceuticals 477.45K
Sonnet BioTherapeutics Holdings 92.73K
Revenue Rankings

NUWE News

More News